GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Shiller PE Ratio

CardioGenics Holdings (CardioGenics Holdings) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CardioGenics Holdings Shiller PE Ratio Historical Data

The historical data trend for CardioGenics Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Shiller PE Ratio Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioGenics Holdings's Shiller PE Ratio

For the Diagnostics & Research subindustry, CardioGenics Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Shiller PE Ratio falls into.



CardioGenics Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CardioGenics Holdings's E10 for the quarter that ended in Jan. 2016 is calculated as:

For example, CardioGenics Holdings's adjusted earnings per share data for the three months ended in Jan. 2016 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2016 (Change)*Current CPI (Jan. 2016)
=-0.001/100.1844*100.1844
=-0.001

Current CPI (Jan. 2016) = 100.1844.

CardioGenics Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200604 -0.200 86.279 -0.232
200607 -0.356 86.595 -0.412
200610 -0.100 86.121 -0.116
200701 -0.700 86.437 -0.811
200704 -0.300 88.175 -0.341
200707 -1.400 88.491 -1.585
200710 0.100 88.175 0.114
200801 -0.600 88.333 -0.681
200804 -0.100 89.676 -0.112
200807 0.000 91.493 0.000
200810 0.000 90.466 0.000
200901 -0.100 89.281 -0.112
200904 0.000 89.992 0.000
200907 -0.420 90.624 -0.464
200910 -0.480 90.545 -0.531
201001 0.000 90.940 0.000
201004 0.000 91.651 0.000
201007 -0.010 92.283 -0.011
201010 -0.010 92.757 -0.011
201101 0.000 93.074 0.000
201104 -0.010 94.654 -0.011
201107 -0.040 94.812 -0.042
201110 -0.050 95.444 -0.052
201201 -0.010 95.365 -0.011
201204 -0.010 96.550 -0.010
201207 0.000 95.997 0.000
201210 0.000 96.550 0.000
201301 0.000 95.839 0.000
201304 0.000 96.945 0.000
201307 0.000 97.261 0.000
201310 -0.040 97.182 -0.041
201401 -0.010 97.261 -0.010
201404 -0.010 98.920 -0.010
201407 -0.010 99.315 -0.010
201410 -0.020 99.473 -0.020
201501 -0.010 98.209 -0.010
201504 0.000 99.710 0.000
201507 -0.010 100.579 -0.010
201510 0.000 100.500 0.000
201601 -0.001 100.184 -0.001

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CardioGenics Holdings  (OTCPK:CGNH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CardioGenics Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines